Dr. Agarwal'S Eye Hospital Ltd (BSE: 526783) is a Chennai, Tamil Nadu-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹2,919 Cr, it ranks #1,072 by market cap among the 6,197 Indian listed companies on FinBizNet, and #19 of 46 in Hospitals and Healthcare Centers. At ₹6,073.00 (as of 16 Nov 2026), the share price is 1.9% below its 52-week high of ₹6,187.50 and 24.0% above its 52-week low of ₹4,899.50. The share price is up 20.0% over one year and up 5.2% over three months.
| Current Price | ₹6,073.00 |
|---|---|
| Market Cap | ₹2,919 Cr |
| BSE Code | 526783 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 41 |
| Return on Equity | 25.22% |
| Return on Assets | 9.03% |
| 52-Week Range | ₹4,899.50 – ₹6,187.50 |
| 1-Year Price Change | +20.0% |
| 3-Month Price Change | +5.2% |
| Beta (1Y) | 0.07 |
| Dividend Yield | 0.13% |
| Headquarters | Chennai, Tamil Nadu |
| Website | www.dragarwal.com |
Delivery averaged 65.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, rosette cataract, and congenital glaucoma. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited operates as a subsidiary of Dr. Agarwal's Health Care Limited.
1. Healthcare Facilities & Services-This segment operates hospital and health related services, nursing homes, clinics, medical, other research institutions, and other health care facilities for eye care and treatment. It is also involved in the trading of optical frames and lens, pharmaceutical products, contact lens and related accessories, and food items. 2. Medical Services-This segment provides eye care services. It also operates pediatric and squint clinics. 3. Trading Activities-This segment sells healthcare equipments. 4. Corporate-0
1. Eye Care Related Sales and Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Dr. Agarwal'S Eye Hospital Ltd | ₹2,919 Cr | 41 | 25.22% | — | +20.0% |
Listed by market capitalisation. Ratios are shown for context only.
Dr. Agarwal'S Eye Hospital Ltd is trading at ₹6,073.00, with a market capitalisation of ₹2,919 Cr.
Dr. Agarwal'S Eye Hospital Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Dr. Agarwal'S Eye Hospital Ltd has a P/E of 41 and a return on equity of 25.22%.
Dr. Agarwal'S Eye Hospital Ltd is listed on the BSE under the scrip code 526783.
Dr. Agarwal'S Eye Hospital Ltd's share price is up 20.0% over one year and up 5.2% over three months. Its 52-week range is ₹4,899.50 to ₹6,187.50.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.